Clinical trial
LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada
NCT07143110 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- August 20, 2025
- Completion date
- September 30, 2027
- Enrollment
- 60,000 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.